PRJNA491639
MULTIPLE ON- AND OFF-TARGET MECHANISMS OF RESISTANCE TO LORLATINIB IN ALK-DRIVEN CANCER IN VITRO AND IN VIVO
These data provide an extensive characterization of resistance mechanisms that may arise in different ALK positive cancers following lorlatinib treatment.